Pathfinders in Biopharma

Perspectives from the cutting edge of biotech and pharma.

The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series.

Lead today. Define tomorrow.

Explore the Series

“Large pharma has $500B it could deploy for M&A.”

What are the challenges and opportunities for the healthcare sector post-pandemic? Where might we see innovations that drive M&A growth?

Biotech Investors: How to Find Value in a Bear Market

How are top investors navigating the longest biotech bear market in almost 20 years?

Listen NowRead Article

Listen Time 29mRead Time 5m

Biotech Outlook 2022: Ample Opportunity for a Rebound

After an historic run in 2020, the biotech sector had a difficult year with slower activity in 2021. The pendulum, however, may be ready to swing back the other way.

Read Article

Read Time 4m

Digital Health Outlook 2022: Opportunities for the Discerning Investor

The digital health market was challenging in 2021, despite the broader macro demand remaining very healthy. While the long term opportunity is clear, the sector is maturing and evolving, which makes it more difficult to pinpoint which strategies or vendors will prevail.

Read Article

Read Time 3m

Global Blood Therapeutics on tackling orphan disease

What does it take to tackle the most perplexing orphan diseases? Ted W. Love, M.D., President and CEO, Global Blood Therapeutics (GBT), speaks with RBC Capital Markets’ Senior Biotechnology Analyst Gregory Renza, M.D. about having a mission and the drive to succeed on this episode of Pathfinders.

Listen NowRead Article

Listen Time 27mRead Time 3m

Subscribe to Future Episodes of Pathfinders

Our podcast series explores the fast-moving world of Biopharma and what the road ahead looks like for companies and investors in the sector.

Subscribe Now

Recent Deals

A Leading Partner for the Biopharma Industry

Our specialty expertise, combined with outstanding execution, has resulted in recurring transactions for biopharma clients as we partner with them through each stage of their development and growth.


More from RBC Capital Markets

Navigating the Changing Face of Healthcare

Navigating the Changing Face of Healthcare

Healthcare is in the midst of a revolution. From the challenges facing individual sectors to breakthrough innovations, gain the insights you need into the forces that are reshaping the industry.

A Leader in Global Insights

A Leader in Global Insights

Access market and industry insights, commentary and analysis from our expert team to gain the perspective you need to make the most informed decisions.

Stay Informed

Get the latest insights from RBC Capital Markets delivered to your inbox.